vs
Side-by-side financial comparison of 60 DEGREES PHARMACEUTICALS, INC. (SXTP) and LQR House Inc. (YHC). Click either name above to swap in a different company.
60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $299.7K, roughly 1.0× LQR House Inc.). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -1368.7%, a 894.6% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -64.2%). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -21.1%).
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
LQR House Inc. is a US-based alcohol beverage e-commerce and distribution company. It offers a broad portfolio of spirits, wine, and beer, operating two core segments: direct-to-consumer retail for individuals and wholesale distribution for business clients across the United States.
SXTP vs YHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $303.4K | $299.7K |
| Net Profit | $-1.4M | $-4.1M |
| Gross Margin | 60.2% | 17.8% |
| Operating Margin | -632.0% | -1000.3% |
| Net Margin | -474.2% | -1368.7% |
| Revenue YoY | 25.6% | -64.2% |
| Net Profit YoY | 29.7% | 72.2% |
| EPS (diluted) | $-8.26 | $2.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $303.4K | $299.7K | ||
| Q3 25 | $437.6K | $337.3K | ||
| Q2 25 | $100.9K | $498.5K | ||
| Q1 25 | $163.6K | $429.3K | ||
| Q4 24 | $241.6K | $838.2K | ||
| Q3 24 | $135.3K | $624.5K | ||
| Q2 24 | $125.0K | $557.9K | ||
| Q1 24 | $105.7K | $481.1K |
| Q4 25 | $-1.4M | $-4.1M | ||
| Q3 25 | $-2.3M | $-16.8M | ||
| Q2 25 | $-1.7M | $-2.2M | ||
| Q1 25 | $-1.9M | $-2.4M | ||
| Q4 24 | $-2.0M | $-14.8M | ||
| Q3 24 | $-2.2M | $-3.4M | ||
| Q2 24 | $-4.2M | $-2.2M | ||
| Q1 24 | $430.5K | $-2.4M |
| Q4 25 | 60.2% | 17.8% | ||
| Q3 25 | -22.9% | 0.4% | ||
| Q2 25 | 50.4% | 17.0% | ||
| Q1 25 | 55.2% | 7.0% | ||
| Q4 24 | 51.1% | -2.3% | ||
| Q3 24 | 17.4% | -9.9% | ||
| Q2 24 | 28.3% | -27.3% | ||
| Q1 24 | 38.1% | -16.5% |
| Q4 25 | -632.0% | -1000.3% | ||
| Q3 25 | -531.4% | -1134.8% | ||
| Q2 25 | -1590.0% | -442.1% | ||
| Q1 25 | -1168.4% | -559.0% | ||
| Q4 24 | -854.7% | -1221.3% | ||
| Q3 24 | -1566.0% | -561.1% | ||
| Q2 24 | -3351.8% | -407.7% | ||
| Q1 24 | -1270.4% | -513.9% |
| Q4 25 | -474.2% | -1368.7% | ||
| Q3 25 | -529.3% | -4989.5% | ||
| Q2 25 | -1717.7% | -441.8% | ||
| Q1 25 | -1147.4% | -556.6% | ||
| Q4 24 | -846.3% | -1760.2% | ||
| Q3 24 | -1596.4% | -538.6% | ||
| Q2 24 | -3339.0% | -396.0% | ||
| Q1 24 | 407.4% | -504.6% |
| Q4 25 | $-8.26 | $2.94 | ||
| Q3 25 | $-0.66 | $-1.50 | ||
| Q2 25 | $-1.25 | $-1.10 | ||
| Q1 25 | $-1.56 | $-3.85 | ||
| Q4 24 | $-51.96 | $-88.71 | ||
| Q3 24 | $-2.92 | $-21.84 | ||
| Q2 24 | $-21.12 | $-15.49 | ||
| Q1 24 | $1.83 | $-18.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.8M | — |
| Total DebtLower is stronger | $150.0K | — |
| Stockholders' EquityBook value | $3.5M | $29.3M |
| Total Assets | $5.4M | $31.2M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.8M | — | ||
| Q3 25 | $4.1M | $10.0M | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $3.5M | — | ||
| Q4 24 | $3.4M | $5.4M | ||
| Q3 24 | $5.0M | $3.7M | ||
| Q2 24 | $1.6M | $4.6M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $150.0K | — | ||
| Q3 25 | $150.0K | — | ||
| Q2 25 | $150.0K | — | ||
| Q1 25 | $150.0K | — | ||
| Q4 24 | $150.0K | — | ||
| Q3 24 | $150.0K | — | ||
| Q2 24 | $150.0K | — | ||
| Q1 24 | $150.0K | — |
| Q4 25 | $3.5M | $29.3M | ||
| Q3 25 | $4.4M | $27.4M | ||
| Q2 25 | $2.4M | $12.2M | ||
| Q1 25 | $4.1M | $7.3M | ||
| Q4 24 | $4.0M | $-518.0K | ||
| Q3 24 | $6.0M | $9.1M | ||
| Q2 24 | $3.0M | $11.7M | ||
| Q1 24 | $7.2M | $12.4M |
| Q4 25 | $5.4M | $31.2M | ||
| Q3 25 | $6.7M | $35.0M | ||
| Q2 25 | $4.2M | $14.4M | ||
| Q1 25 | $6.0M | $9.6M | ||
| Q4 24 | $5.8M | $6.9M | ||
| Q3 24 | $7.4M | $9.8M | ||
| Q2 24 | $4.3M | $12.2M | ||
| Q1 24 | $8.4M | $12.9M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.03× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-14.3M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -584.2% | — |
| Capex IntensityCapex / Revenue | 26.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | $-14.3M | ||
| Q3 25 | $-2.1M | $-11.3M | ||
| Q2 25 | $-1.5M | $-1.6M | ||
| Q1 25 | $-1.6M | $-6.6M | ||
| Q4 24 | $-1.6M | $-3.1M | ||
| Q3 24 | $-1.7M | $-1.0M | ||
| Q2 24 | $-1.2M | $-1.2M | ||
| Q1 24 | $-1.1M | $-1.4M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-2.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | -584.2% | — | ||
| Q3 25 | -484.2% | — | ||
| Q2 25 | -1483.6% | — | ||
| Q1 25 | -978.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1252.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -287.7% |
| Q4 25 | 26.3% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 46.9% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.65× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
